Icantgetup Posted - 22 hours ago

$NVRO I have not even read it yet. But here is a prediction...losses again.

Stock_Titan Posted - 2 days ago

$NVRO Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024 https://www.stocktitan.net/news/NVRO/nevro-to-report-first-quarter-2024-financial-results-and-host-ah5uygekjdgd.html

Thestocktraderhubzee Posted - 3 days ago

WATCHLIST APR 16 2024. $BERY Baird Downgrades Berry Global Gr to Neutral, Lowers Price Target to $65 $CCK Baird Upgrades Crown Holdings to Outperform, Raises Price Target to $90 $NVRO RBC Capital Maintains Outperform on Stryker, Raises Price Target to $386 $PGR Citigroup Maintains Neutral on Progressive, Raises Price Target to $225 $TV B of A Securities Downgrades Grupo Televisa to Neutral, Announces $3.5 Price Target

stokpiks Posted - 1 week ago

"The key takeaway here is that SofPulse, Inc. is taking over SofPulse® and being spun out into a new public entity intended to list on NASDAQ via IPO. " Read more: https://smpl.is/8yhx4 $ENDV $MDT $NVRO $NGENF

Icantgetup Posted - 03/22/24

$NVRO when will it be so low that someone risks taking it over?

Stock_Titan Posted - 02/28/24

$NVRO Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw https://www.stocktitan.net/news/NVRO/nevro-receives-fda-510-k-clearance-to-use-si-fixation-system-without-1jc72z16ve6c.html

VrtcIl Posted - 02/22/24

How much more potential do you see on $NVRO? 18? 27? 37? Look for key indicators such as trend strength, support and resistance levels, and potential breakout or reversal patterns. Price: 17.34 Float: 34.9M Short Float: 13.8 % 💰 Dollar Volume: 172.3K ℹ️ USA | Medical Devices

OpenOutcrier Posted - 02/22/24

$NVRO (+3.5% pre) Nevro Corp earnings beat by $0.24, revenue topped estimates - inv https://ooc.bz/l/25721

Estimize Posted - 02/21/24

$NVRO beats the Estimize EPS Consensus by 24c and the Estimize Revenue Consensus by $0.21M. Reports FQ4 earnings of -25c EPS and $116.1... http://www.estimize.com/nvro/fq4-2023?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

epsguid Posted - 02/21/24

$NVRO reported a loss of $0.15, consensus was ($0.50), Earnings Whisper was ($0.45) via @eWhispers #whisperbeat http://eps.sh/d/nvro

Stock_Titan Posted - 02/21/24

$NVRO Nevro Enters Into Cooperation Agreement With Engaged Capital https://www.stocktitan.net/news/NVRO/nevro-enters-into-cooperation-agreement-with-engaged-p6fes9s0rbkw.html

Stock_Titan Posted - 02/21/24

$NVRO Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results https://www.stocktitan.net/news/NVRO/nevro-reports-fourth-quarter-and-full-year-2023-financial-k5yslqv5rb3c.html

Estimize Posted - 02/21/24

$NVRO reports after the close, Estimize Consensus -0 EPS and +3.71M Revs compared to WS http://www.estimize.com/nvro/fq4-2023?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

DataJim Posted - 01/23/24

$NGENF Chronic spinal cord injury Enrollment complete guess - 2/6/24 $NVRO $BSX $SYK https://blinkofaneye.org/nervgen-clinical-trial-blink-acts-as-screener/

ChartMill Posted - 3 months ago

$NVRO: Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy https://www.chartmill.com/stock/quote/NVRO/news?utm_source=prnews-2024-1-18-nevro-announces-positive-coverage-update-from-carelon-healthcare-for-the-treatment-of-painful-diabetic-neuropathy&utm_medium=stocktwits&utm_campaign=pressRelease

ChartMill Posted - 3 months ago

$NVRO: Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting https://www.chartmill.com/stock/quote/NVRO/news?utm_source=prnews-2024-1-17-nevro-to-highlight-25-scientific-abstracts-at-2024-north-american-neuromodulation-society-nans-annual-meeting&utm_medium=stocktwits&utm_campaign=pressRelease

risenhoover Posted - 3 months ago

$NVRO NVRO / Nevro Corp. downgraded by RBC Capital https://fintel.io/sfo/us/nvro?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=upgrade

cctranscripts Posted - 3 months ago

Notice of Effectiveness https://www.conferencecalltranscripts.org/summary/?id=12859597 $NVRO

cctranscripts Posted - 3 months ago

NEVRO CORP just filed a prospectus, suggesting it plans to soon issue some securities https://www.conferencecalltranscripts.org/summary/?id=12858370 $NVRO

EarningsInsider Posted - 3 months ago

$NVRO updates FY 2023 guidance to EPS and revenue guidance to $425.0 million-$425.0 million. www.marketbeat.com/stocks/NYSE/NVRO/earnings/

EarningsInsider Posted - 3 months ago

$NVRO updates Q4 2023 guidance to EPS and revenue guidance to $116.0 million-$116.0 million. www.marketbeat.com/stocks/NYSE/NVRO/earnings/

DonCorleone77 Posted - 3 months ago

$NVRO Nevro announces restructuring plan, 5% workforce reduction In a regulatory filing, Nevro announced that on January 6, 2024, the company approved a restructuring plan that includes laying off 63 employees, which represented approximately 5% of the company's total number of employees. The Restructuring affects employees in corporate, sales and marketing, and operations positions but is largely focused on internally facing roles within the company. This action was taken to support the company's strategy and allow it to focus its investments to further position the company for long-term growth and profitability. The company expects the Restructuring to have a $14M-$15M positive impact on its full-year 2024 adjusted EBITDA, which will be largely offset by normal operating expense increases, including inflation, merit increases and other acquisition-related expenses. In addition, GAAP operating expenses in the first quarter of 2024 will reflect a $5M-$6M restructuring charge....

Last10K Posted - 3 months ago

$NVRO just filed with the SEC a Earnings Release, a New Costs and a Financial Exhibit https://last10k.com/sec-filings/NVRO/0000950170-24-003196.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=NVRO

cctranscripts Posted - 3 months ago

Nevro Announces Preliminary Fourth-Quarter https://www.conferencecalltranscripts.org/summary/?id=12853243 $NVRO

risenhoover Posted - 3 months ago

Also, if you are new to $NVRO here's a background article on Finpedia for you https://finpedia.co/bin/Nevro%20Corp/

risenhoover Posted - 3 months ago

$NVRO / Nevro files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 https://fintel.io/doc/sec-nevro-corp-1444380-8k-2024-january-09-19731-205?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Stock_Titan Posted - 3 months ago

$NVRO Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results https://www.stocktitan.net/news/NVRO/nevro-announces-preliminary-fourth-quarter-and-full-year-2023-gzs2v8lqjmfk.html

cctranscripts Posted - 3 months ago

NEVRO CORP insider just disposed of 526 shares https://www.conferencecalltranscripts.org/summary/?id=12851810 $NVRO

ChartMill Posted - 3 months ago

$NVRO: Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference https://www.chartmill.com/stock/quote/NVRO/news?utm_source=prnews-2024-1-4-nevro-to-present-at-42nd-annual-jp-morgan-healthcare-conference&utm_medium=stocktwits&utm_campaign=pressRelease

Stock_Titan Posted - 3 months ago

$NVRO Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference https://www.stocktitan.net/news/NVRO/nevro-to-present-at-42nd-annual-j-p-morgan-healthcare-xo0dxnvzkgrp.html